Serological diagnosis of mumps: Value of the titration of specific IgG

Limia Sánchez, 2015, Programa y coberturas de vacunación frente a sarampión y rubéola en España. Retos para alcanzar su eliminación, Rev Esp Salud Publica, 89, 357, 10.4321/S1135-57272015000400004 Sanz, 2008, Evolución de los casos de parotiditis confirmados serológicamente en la Comunidad de Madrid durante un período de 7 años (2000–2006), Med Clin (Barc), 130, 292, 10.1157/13116573 Dayan, 2008, Mumps outbreaks in vaccinated populations: are available mumps vaccines effective enough to prevent outbreaks?, Clin Infect Dis, 47, 1458, 10.1086/591196 Barskey, 2009, Mumps resurgences in the United States: a historical perspective on unexpected elements, Vaccine, 27, 6186, 10.1016/j.vaccine.2009.06.109 Date, 2008, Long-term persistence of mumps antibody after receipt of 2 measles-mumps-rubella (MMR) vaccinations and antibody response after a third MMR vaccination among a university population, J Infect Dis, 197, 1662, 10.1086/588197 Centro Nacional de Epidemiología. Instituto de Salud Carlos III, 2013 Hatchette, 2009, Laboratory diagnosis of mumps in a partially immunized population: the Nova Scotia experience, Can J Infect Dis Med Microbiol, 20, e157, 10.1155/2009/493275 Rota, 2013, Comparison of the sensitivity of laboratory diagnostic methods from a well-characterized outbreak of mumps in New York city in 2009, Clin Vaccine Immunol, 20, 391, 10.1128/CVI.00660-12 Sanz-Moreno, 2005, Detection of secondary mumps vaccine failure by means of avidity testing for specific immunoglobulin G, Vaccine, 23, 4921, 10.1016/j.vaccine.2005.05.018 Krause, 2007, Comparison of mumps-IgM ELISAs in acute infection, J Clin Virol, 38, 153, 10.1016/j.jcv.2006.10.010